These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 17339443)

  • 1. Differential survival of cytotoxic T cells and memory cell precursors.
    Zhang M; Byrne S; Liu N; Wang Y; Oxenius A; Ashton-Rickardt PG
    J Immunol; 2007 Mar; 178(6):3483-91. PubMed ID: 17339443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for the granzyme B inhibitor serine protease inhibitor 6 in CD8+ memory cell homeostasis.
    Phillips T; Opferman JT; Shah R; Liu N; Froelich CJ; Ashton-Rickardt PG
    J Immunol; 2004 Sep; 173(6):3801-9. PubMed ID: 15356127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serpinb9 (Spi6)-deficient mice are impaired in dendritic cell-mediated antigen cross-presentation.
    Rizzitelli A; Meuter S; Vega Ramos J; Bird CH; Mintern JD; Mangan MS; Villadangos J; Bird PI
    Immunol Cell Biol; 2012 Oct; 90(9):841-51. PubMed ID: 22801574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serine protease inhibitor-6 differentially affects the survival of effector and memory alloreactive CD8-T cells.
    Azzi J; Ohori S; Ting C; Uehara M; Abdoli R; Smith BD; Safa K; Solhjou Z; Lukyanchykov P; Patel J; McGrath M; Abdi R
    Am J Transplant; 2015 Jan; 15(1):234-41. PubMed ID: 25534448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serine protease inhibitor 6 plays a critical role in protecting murine granzyme B-producing regulatory T cells.
    Azzi J; Skartsis N; Mounayar M; Magee CN; Batal I; Ting C; Moore R; Riella LV; Ohori S; Abdoli R; Smith B; Fiorina P; Heathcote D; Bakhos T; Ashton-Rickardt PG; Abdi R
    J Immunol; 2013 Sep; 191(5):2319-27. PubMed ID: 23913965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serine protease inhibitor 6 is required to protect dendritic cells from the kiss of death.
    Lovo E; Zhang M; Wang L; Ashton-Rickardt PG
    J Immunol; 2012 Feb; 188(3):1057-63. PubMed ID: 22227570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serine protease inhibitor 6 protects cytotoxic T cells from self-inflicted injury by ensuring the integrity of cytotoxic granules.
    Zhang M; Park SM; Wang Y; Shah R; Liu N; Murmann AE; Wang CR; Peter ME; Ashton-Rickardt PG
    Immunity; 2006 Apr; 24(4):451-61. PubMed ID: 16618603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spi6 protects alloreactive CD4(+) but not CD8 (+) memory T cell from granzyme B attack by double-negative T regulatory cell.
    Su Y; Jevnikar AM; Huang X; Lian D; Zhang Z-
    Am J Transplant; 2014 Mar; 14(3):580-93. PubMed ID: 24730048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serine protease inhibitor 6 protects iNKT cells from self-inflicted damage.
    Ansari AW; Temblay JN; Alyahya SH; Ashton-Rickardt PG
    J Immunol; 2010 Jul; 185(2):877-83. PubMed ID: 20543105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathepsin B controls the persistence of memory CD8+ T lymphocytes.
    Byrne SM; Aucher A; Alyahya S; Elder M; Olson ST; Davis DM; Ashton-Rickardt PG
    J Immunol; 2012 Aug; 189(3):1133-43. PubMed ID: 22745374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serine protease inhibitor 2A is a protective factor for memory T cell development.
    Liu N; Phillips T; Zhang M; Wang Y; Opferman JT; Shah R; Ashton-Rickardt PG
    Nat Immunol; 2004 Sep; 5(9):919-26. PubMed ID: 15311278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells express serine protease inhibitor to evade the host immune response.
    El Haddad N; Heathcote D; Moore R; Yang S; Azzi J; Mfarrej B; Atkinson M; Sayegh MH; Lee JS; Ashton-Rickardt PG; Abdi R
    Blood; 2011 Jan; 117(4):1176-83. PubMed ID: 21076046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPI-CI and SPI-6 cooperate in the protection from effector cell-mediated cytotoxicity.
    Bots M; Kolfschoten IG; Bres SA; Rademaker MT; de Roo GM; Krüse M; Franken KL; Hahne M; Froelich CJ; Melief CJ; Offringa R; Medema JP
    Blood; 2005 Feb; 105(3):1153-61. PubMed ID: 15454490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.
    Mortarini R; Piris A; Maurichi A; Molla A; Bersani I; Bono A; Bartoli C; Santinami M; Lombardo C; Ravagnani F; Cascinelli N; Parmiani G; Anichini A
    Cancer Res; 2003 May; 63(10):2535-45. PubMed ID: 12750277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of cytotoxic granules in human memory CD8+ T cell subsets requires cell cycle progression.
    Meng Y; Harlin H; O'Keefe JP; Gajewski TF
    J Immunol; 2006 Aug; 177(3):1981-7. PubMed ID: 16849512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of human granzymes A, B, and K in natural killer cells and during CD8+ T cell differentiation in peripheral blood.
    Bratke K; Kuepper M; Bade B; Virchow JC; Luttmann W
    Eur J Immunol; 2005 Sep; 35(9):2608-16. PubMed ID: 16106370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three memory subsets of human CD8+ T cells differently expressing three cytolytic effector molecules.
    Takata H; Takiguchi M
    J Immunol; 2006 Oct; 177(7):4330-40. PubMed ID: 16982867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical role for granzyme B, in addition to perforin and TNFalpha, in alloreactive CTL-induced mouse pancreatic beta cell death.
    Sutton VR; Estella E; Li C; Chen M; Thomas HE; Kay TW; Trapani JA
    Transplantation; 2006 Jan; 81(2):146-54. PubMed ID: 16436955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role for monocyte chemoattractant protein-1 in the generation and function of memory CD8+ T cells.
    Wang T; Dai H; Wan N; Moore Y; Dai Z
    J Immunol; 2008 Mar; 180(5):2886-93. PubMed ID: 18292510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The intracellular granzyme B inhibitor, proteinase inhibitor 9, is up-regulated during accessory cell maturation and effector cell degranulation, and its overexpression enhances CTL potency.
    Hirst CE; Buzza MS; Bird CH; Warren HS; Cameron PU; Zhang M; Ashton-Rickardt PG; Bird PI
    J Immunol; 2003 Jan; 170(2):805-15. PubMed ID: 12517944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.